ESR1 and cancer: Elucidation of such novel approaches for endometrial and ovarian cancer-specific pathways in combination with the use of selective intracrine modulators or selective estrogen-receptor modulators may lead to the development of novel therapeutic approaches to improve the success of cancer chemotherapy.